Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15259585 | 0.88 | KDM4E (0.57) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL5113547 | 0.85 | MAPT (0.49) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL2175829 | 0.84 | CYP1A2 (0.75) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL29537172 | 0.84 | CYP1A2 (0.75) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL9537879 | 0.83 | L3MBTL1 (0.52) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL27782792 | 0.81 | CYP1A2 (0.56) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL29840068 | 0.78 | GAA (0.67) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| Cyclopropane SCHEMBL29022116 | 0.78 | CYP1A2 (0.68) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL2068768 | 0.78 | LMNA (0.68) | CYP1A2KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL3928666 | 0.78 | GAA (0.67) | CYP1A2KDM4EMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210219546-A1 | METHODS OF TREATING CROP PLANTS | ALTER DOMUS US LLC | 2021-07-22 | — | — | US | disclosed |
| EP-3294052-A1 | METHODS OF TREATING CROP PLANTS | Agrofresh, Inc. (US) | 2018-03-21 | — | — | EP | disclosed |
| WO-2016182995-A1 | METHODS OF TREATING CROP PLANTS | AGROFRESH INC (US) | 2016-11-17 | — | — | WO | disclosed |
| US-20150282479-A1 | METHODS OF TREATING CROP PLANTS | AGROFRESH, INC. | 2015-10-08 | — | — | US | disclosed |
| US-9055741-B2 | Contacting crop plants with compositions | ROHM AND HAAS COMPANY (US) | 2015-06-16 | — | — | US | disclosed |
| EP-1856976-B1 | Contacting crop plants with compositions | ROHM & HAAS (US) | 2014-09-03 | — | — | EP | disclosed |
| EP-2070419-A1 | A liquid composition for treating plants | Rohm and Haas Company (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-1856976-A2 | Contacting crop plants with compositions | Rohm and Haas Company (US) | 2007-11-21 | — | — | EP | disclosed |
| US-20070265166-A1 | Contacting crop plants with compositions | ALTER DOMUS US LLC | 2007-11-15 | — | — | US | disclosed |
| US-20070117720-A1 | Compositions with cyclopropenes | AGROFRESH, INC. | 2007-05-24 | — | — | US | disclosed |
| EP-1787513-A2 | Compositions with cyclopropenes | Rohm and Haas Company (US) | 2007-05-23 | — | — | EP | disclosed |
| US-20060160704-A1 | Plant growth regulation | BASEL RICHARD M | 2006-07-20 | — | — | US | disclosed |
| EP-1680960-A1 | Plant growth regulation | Rohm and Haas Company (US) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265166-A1 | Contacting crop plants with compositions | PIN1, MYB, CROCC | CYP1A2 834/4885KDM4E 1920/4885MEN1 4248/4885 |
| US-20060160704-A1 | Plant growth regulation | MYB, SLTM, YAP1 | CYP1A2 798/4885KDM4E 2520/4885MEN1 3961/4885 |
| US-20150282479-A1 | METHODS OF TREATING CROP PLANTS | CYCS, NOP2, CNPY3 | CYP1A2 1237/4885KDM4E 3297/4885MEN1 4372/4885 |
| US-20070117720-A1 | Compositions with cyclopropenes | MYB, OSBP, FAR1 | CYP1A2 873/4885KDM4E 4041/4885MEN1 3749/4885 |
| US-20210219546-A1 | METHODS OF TREATING CROP PLANTS | CYCS, NOP2, CNPY3 | CYP1A2 1237/4885KDM4E 3297/4885MEN1 4372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.